| 常用名 | N-羟基-2-[4-(2-萘基磺酰基)-1-哌嗪基]-5-嘧啶甲酰胺 | CAS号 | 604769-01-9 |
|---|---|---|---|
| 价格 | $需询单/100g $需询单/1kg $需询单/100kg $需询单/1000kg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: JNJ-16241199 is an orally active, selective hydroxamate-based histone deacetylase (HDAC) inhibitor, with the IC50 of 3.3 nM and 23 nM for HDAC1 and HDAC8, respectively. JNJ-16241199 induces histone 3 acetylation and strongly increases the expression of p21waf1, cip1 in A2780 ovarian carcinoma cells. JNJ-16241199 induces cell apoptosis and shows anticancer activity in a broad spectrum of human malignancies. JNJ-16241199 can be used for cancer study[1]. 物理化学性质: CAS号:604769-01-9 常用中文名:N-羟基-2-[4-(2-萘基磺酰基)-1-哌嗪基]-5-嘧啶甲酰胺 常用英文名:R306465 分子式:C19H19N5O4S 分子量:413.45 密度:1.5±0.1 g/cm3 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:-20°C,密闭,干燥 |